First Hawaiian Bank’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-2,995
| Closed | -$2.13M | – | 603 |
|
2024
Q4 | $2.13M | Buy |
2,995
+474
| +19% | +$338K | 0.07% | 211 |
|
2024
Q3 | $2.65M | Sell |
2,521
-103
| -4% | -$108K | 0.08% | 164 |
|
2024
Q2 | $2.76M | Sell |
2,624
-36
| -1% | -$37.8K | 0.09% | 153 |
|
2024
Q1 | $2.56M | Sell |
2,660
-499
| -16% | -$480K | 0.08% | 187 |
|
2023
Q4 | $2.77M | Sell |
3,159
-709
| -18% | -$623K | 0.09% | 165 |
|
2023
Q3 | $3.18M | Buy |
3,868
+6
| +0.2% | +$4.94K | 0.11% | 133 |
|
2023
Q2 | $2.78M | Buy |
3,862
+231
| +6% | +$166K | 0.09% | 163 |
|
2023
Q1 | $2.98M | Sell |
3,631
-1,013
| -22% | -$832K | 0.1% | 144 |
|
2022
Q4 | $3.35M | Buy |
4,644
+443
| +11% | +$320K | 0.12% | 112 |
|
2022
Q3 | $2.89M | Sell |
4,201
-114
| -3% | -$78.5K | 0.11% | 126 |
|
2022
Q2 | $2.55M | Sell |
4,315
-348
| -7% | -$206K | 0.09% | 160 |
|
2022
Q1 | $3.26M | Buy |
4,663
+2,388
| +105% | +$1.67M | 0.1% | 135 |
|
2021
Q4 | $1.44M | Sell |
2,275
-103
| -4% | -$65.1K | 0.04% | 303 |
|
2021
Q3 | $1.44M | Sell |
2,378
-5
| -0.2% | -$3.03K | 0.06% | 215 |
|
2021
Q2 | $1.33M | Sell |
2,383
-1,053
| -31% | -$588K | 0.06% | 229 |
|
2021
Q1 | $1.63M | Buy |
3,436
+178
| +5% | +$84.2K | 0.07% | 200 |
|
2020
Q4 | $1.57M | Buy |
3,258
+1,172
| +56% | +$566K | 0.07% | 199 |
|
2020
Q3 | $1.17M | Sell |
2,086
-368
| -15% | -$206K | 0.06% | 223 |
|
2020
Q2 | $1.53M | Sell |
2,454
-400
| -14% | -$250K | 0.08% | 180 |
|
2020
Q1 | $1.39M | Sell |
2,854
-935
| -25% | -$457K | 0.08% | 164 |
|
2019
Q4 | $1.42M | Buy |
3,789
+758
| +25% | +$284K | 0.07% | 210 |
|
2019
Q3 | $841K | Hold |
3,031
| – | – | 0.04% | 304 |
|
2019
Q2 | $949K | Sell |
3,031
-850
| -22% | -$266K | 0.05% | 267 |
|
2019
Q1 | $1.59M | Sell |
3,881
-80
| -2% | -$32.8K | 0.09% | 172 |
|
2018
Q4 | $1.48M | Buy |
3,961
+346
| +10% | +$129K | 0.09% | 159 |
|
2018
Q3 | $1.46M | Buy |
+3,615
| New | +$1.46M | 0.08% | 197 |
|